Jiangsu Hengrui Pharmaceuticals (600276.SH) announced that, as of September 30, 2024, the company has conducted centralized auction trading...
According to the report from the Zhitong Finance and Economics APP, Jiangsu Hengrui Pharmaceuticals (600276.SH) announced that, as of September 30, 2024, the company has repurchased a total of 4.5561 million shares through centralized auction trading, accounting for 0.07% of the total share capital of the company. The highest transaction price was 42.77 yuan/share, the lowest price was 39.00 yuan/share, and the total amount paid was 0.187 billion yuan (excluding transaction costs).